Orthofix Medical Inc.
OFIX | NASDAQ
$8.95
+$0.24 (+2.76%)
At close: Sep 21, 2026, 4:00 PM ET
$9.02
+$0.07 (+0.82%)
Pre-market:
Sep 22, 2026, 4:42 AM ET
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Revenue | 822.31M | 799.49M | 746.64M | 460.71M | 464.48M | 406.56M |
Cost of Revenue | 270.61M | 253.61M | 260.37M | 123.54M | 114.91M | 101.89M |
Gross Profit | 551.71M | 545.89M | 486.27M | 337.17M | 349.57M | 304.67M |
Operating Income | -68.47M | -84.62M | -139.11M | -13.27M | -8.32M | -6.27M |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -90.81M | -123.88M | -148.68M | -17.71M | -13.5M | -368K |
Net Income | -92.19M | -126M | -151.4M | -19.75M | -38.38M | 2.52M |
Selling & General & Admin | 456.39M | 532.53M | 530.4M | 308.78M | 290.67M | 272.38M |
Research & Development | 57.11M | 73.64M | 80.23M | 49.07M | 49.62M | 39.06M |
Other Expenses | 106.68M | 24.34M | 14.76M | -7.4M | 17.59M | -499K |
Operating Expenses | 620.18M | 630.5M | 625.38M | 350.44M | 357.88M | 310.94M |
Interest Expense | 17.49M | 29.63M | 8.63M | 1.29M | 1.84M | 2.48M |
Selling & Marketing Expenses | n/a | n/a | 385.74M | 228.81M | 221.32M | 204.43M |
Cost & Expenses | 890.78M | 884.11M | 885.75M | 473.98M | 472.79M | 412.83M |
Income Tax Expense | 1.38M | 2.12M | 2.72M | 2.04M | 24.88M | -2.89M |
Shares Outstanding (Basic) | 39.88M | 38.13M | 36.73M | 20.1M | 19.69M | 19.27M |
Shares Outstanding (Diluted) | 39.88M | 38.13M | 36.73M | 20.1M | 19.69M | 19.39M |
EPS (Basic) | -2.28 | -3.30 | -4.12 | -0.98 | -1.95 | 0.13 |
EPS (Diluted) | -2.28 | -3.30 | -4.12 | -0.98 | -1.95 | 0.13 |
EBITDA | -22.35M | -34.18M | -79.49M | 15.66M | 21.44M | 36.39M |
EBIT | -73.32M | -94.24M | -140.05M | -16.42M | -11.66M | 2.12M |
Depreciation & Amortization | 50.97M | 60.06M | 60.56M | 32.08M | 33.1M | 34.28M |
Add to Watchlist
Select watchlists to add or remove OFIX